ArticleStem cell research & therapy2026
Clinically adaptable size cartilage grafts generated from human embryonic stem cells enable tracheal repair in a porcine model.
Article in Stem cell research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
introductionAutologous costal cartilage grafting is commonly used for pediatric tracheal reconstruction; however, it has several limitations, including restricted availability and surgical invasiveness. In this study, we investigated the feasibility of a novel tracheal reconstruction approach using human embryonic stem cell-derived cartilage tissue (ESCaT).
methodsESCaT was differentiated from human embryonic stem cells (SEES2), and large-scale cartilage constructs were generated by integrating tissues derived from multiple culture dishes within a nylon mesh scaffold. Decellularized ESCaT (dESCaT) was subsequently produced using a high hydrostatic pressure method. These constructs were transplanted into a porcine tracheal defect model, and airway patency, histological changes, and immune responses were evaluated. In addition, similar analyses were performed in operational immunodeficient pigs (OIDPs) treated with immunosuppressive regimens.
resultsESCaT was reproducibly generated as plate-shaped constructs with an average size of 18.2 × 14.2 × 4.4 mm, exhibiting sufficient mechanical strength to withstand suturing and airway pressure. In non-treated pigs, both ESCaT and dESCaT induced strong inflammatory responses after transplantation, resulting in loss or replacement of cartilage tissue. In contrast, in the OIDP model, dESCaT grafts were maintained, and airway patency ranged from 84.7% to 100.8%. Histological analysis revealed only mild inflammatory cell infiltration, along with evidence of epithelial regeneration.
conclusionsESCaT demonstrates clinically relevant size and mechanical strength, indicating its potential as a graft material for tracheal reconstruction. However, immune responses in xenogeneic transplantation remain a major challenge, and the combination of decellularization and immunomodulation is critical for graft survival. Further studies are required to reduce immunogenicity and optimize tissue maturation for future clinical applications.
Indexed as
Identifiers
42920173What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.